There Are More Publicly-Traded Hemp Cannabinoids Companies

I wrote last week about how a cannabis company I follow, Organigram (OGI), has beefed up its presence in the American hemp-derived THC market . Today, I want to follow up on some other companies that are in that space. I have already mentioned how the Big 3 American cannabis companies, Curaleaf (CURLF), Green Thumb Industries (GTBIF) and Trulieve (TCNNF) have beverage efforts. I warned about those companies at New Cannabis Ventures when I introduced this blog in my weekly newsletter there in early July. Two Canadian LPs that I really don't like in terms of stock price, Canopy Growth (CGC) and Tilray Brands (TLRY) have efforts in this market too.

Today, I want to discuss two other companies that are active and much smaller. If they succeed immensely, their stocks could soar due to their size. I used to follow one very closely, Charlotte's Web (CWBHF), and I have been aware of the other one, cbdMD (YCBD) for a long time.

YCBD is tiny! It has a market cap of just $12 million. It has rallied sharply recently, but it is down a ton over the past 5 years:

The company owns a Florida-based company, Herbal Oasis, that entered into a drink distribution deal last week. The company reported fiscal Q3 revenue of just $4.6 million in August, and it is expected to generate revenue for FY26 (ending in September) of $20.2 million by a single analyst. YCBD loses money.

Charlotte's Web today got an analyst rating of Overweight from Zuanic & Associates:

Zuanic on CWBHF.pdf

Download PDF • 1.66MB

It is not like that firm to say things like "We see 50% upside by Dec’26". Note that it also says at the end of the report that the company is a paying client. Hmm.

I used to really like this company, but I removed it from my Focus List a while ago as it became very clear that the FDA had no interest in regulating CBD. Like YCBD, CWBHF, which trades on the TSX in Canada but on the OTC in the U.S. has been hammered over the past 5 years:

Charlotte's Web is bigger than cbdMD, with a market cap of about $27 million, but this is tiny too. The company reported Q2 revenue of $12.7 million and has no analyst coverage. Zuanic did project 2026 revenue of $57.4 million with a loss.

While these stocks have been decimated, I don't cover either of them at 420 Investor. I am watching YCBD more closely, but I share a chart of these stocks and some others each week with my subscribers. The action for both in H2 of this year is interesting:

This blog is focused on THC derived from hemp. I am focused on cannabis stocks, but not here on this blog. These stocks are flying, but I don't cover either of them at 420 Investor.

The THC world got some interesting news this week from Target (TGT) in that it is trialing THC beverage sales in Minnesota. An article on Bloomberg News explained:

The products are available in Target liquor stores, which are located within Target stores and have their own entrance. Shoppers must be 21 to purchase items, and there’s a cap of 5 milligrams of THC content.

I have shared a lot here on Total Wine, and it is very aggressive in the industry. I haven't yet added Target to the list of cannabis companies focused on hemp products at New Cannabis Ventures due to this being a "trial" for now and such a small part of the overall company, but it could be very big news.

THC beverages and other hemp-derived cannabinoid products could boom, but they also face huge regulatory risk from states and the federal government.